
    
      This study is a prospective, multicentred randomized controlled trial, planning to enroll 430
      subjects and randomize 1:1 to study group and control group.

      All subjects will accept clinical evaluation at 1 month, 6 month, 9 month and 1, 2, 3, 4, 5
      year post procedure.

      All subjects will accept angiographic evaluation at 1 year post procedure, and simutaneously
      80 subjects (40 in study group and 40 in control group) will accepted OCT evaluation.

      To assess the efficacy and safety, the primary endpoint will be in segment late luminal loss
      at 1 year post procedure, the secondary endpoint is neointima coverage percentage of stent
      strut (%) at 1 year post procedure.
    
  